Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,275.00
-30.00 (-1.30%)
At close: Sep 18, 2026

Biotoxtech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14,85018,63211,37027,47912,70018,592
Short-Term Investments
10,0009,50019,00013,55917,0599,559
Trading Asset Securities
4,405-2,014-1,012-
Cash & Short-Term Investments
29,25528,13232,38441,03830,77128,151
Cash Growth
5.70%-13.13%-21.09%33.37%9.31%32.97%
Accounts Receivable
7,9138,7007,8635,3557,3525,813
Other Receivables
395.96376.02462.71445.37158.21,055
Receivables
11,01211,8039,9188,39210,2618,631
Inventory
10,3267,21814,78611,9154,454674.04
Prepaid Expenses
537.91187.05423.32113.14257.66202.19
Other Current Assets
1,3861,2751,4063,2333,38788.11
Total Current Assets
52,51748,61558,91864,69249,13037,746
Property, Plant & Equipment
55,41255,07156,51658,18158,06625,409
Long-Term Investments
15,29718,90210,32010,68910,13018,373
Other Intangible Assets
1,0721,2761,6651,5961,4831,479
Long-Term Deferred Tax Assets
1,011732.721,8525,3441,072565.72
Long-Term Deferred Charges
-----58.46
Other Long-Term Assets
2,8852,8152,0931,865819.422,110
Total Assets
132,353131,607136,191147,036125,70090,741

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
583.18687.72673.72541.98783.54815.54
Accrued Expenses
748.79689.13183.2280.55628.1
Short-Term Debt
53,49346,03742,81841,22927,85323,843
Current Portion of Long-Term Debt
5,0005,0003,750-1,0001,000
Current Portion of Leases
191.65135.06165.46171.03150.43199.46
Current Income Taxes Payable
----250.2948.79
Current Unearned Revenue
111.46----
Other Current Liabilities
36,94032,93234,61933,09629,43519,841
Total Current Liabilities
96,95885,49282,21075,11959,52845,777
Long-Term Debt
9,55011,25016,25020,00020,0001,909
Long-Term Leases
124.0777.9165.74191.59136.8197.13
Pension & Post-Retirement Benefits
3,3042,6713,0413,3201,5081,070
Other Long-Term Liabilities
32.32184.5299.68171.68161.138.12
Total Liabilities
109,96999,676101,66698,80181,33448,892

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
7,9797,9797,9797,9797,3347,334
Additional Paid-In Capital
32,51632,51632,51634,12521,59821,058
Retained Earnings
-6,5161,16158.566,74012,1629,354
Treasury Stock
-2,161-2,161-1,163-165.68-165.68-165.68
Comprehensive Income & Other
686.79662.67691.383,0323,3073,563
Total Common Equity
32,50540,15740,08251,71044,23541,144
Minority Interest
-10,121-8,226-5,557-3,475131.97705.69
Shareholders' Equity
22,38431,93134,52548,23544,36741,849
Total Liabilities & Equity
132,353131,607136,191147,036125,70090,741

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
68,35962,50063,04961,59149,14027,049
Net Cash (Debt)
-39,104-34,367-30,665-20,553-18,3691,102
Net Cash Growth
------71.82%
Net Cash Per Share
-2532.09-2199.82-1932.30-1332.10-1255.0371.58
Filing Date Shares Outstanding
15.4115.4115.7215.9314.6414.64
Total Common Shares Outstanding
15.4115.4115.7215.9314.6414.64
Working Capital
-44,441-36,877-23,292-10,426-10,398-8,031
Book Value Per Share
2109.862606.612549.633246.603022.262811.05
Tangible Book Value
31,43238,88238,41750,11542,75239,665
Tangible Book Value Per Share
2040.262523.812443.713146.422920.962710.03
Land
6,6686,6686,6686,6686,6686,650
Buildings
52,05351,81751,80851,45851,21322,710
Machinery
15,84314,19513,69413,20310,9134,666
Construction In Progress
2.021.44651.78131.61,654